Response to Comments: Glucose Monitors – DL33822

This document is a response-to-comments summary for the proposed Glucose Monitors LCD (DL33822), covering a 45-day public comment period from October 6, 2022 through November 19, 2022. It states that DME MACs reviewed submitted comments (with possible consolidation or redaction) and that final coverage determinations are based on available evidence of general acceptance per the CMS Program Integrity Manual (Pub. 100-08) Chapter 13. The provided excerpt does not contain specific coverage, exclusion, documentation, or frequency criteria for glucose monitors.